Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trevena Inc (EM) TRVN

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.


EXPM:TRVN - Post by User

User Avatar Image
(5)
•••
  • GolongGekkoX
Comment by GolongGekkoon Oct 07, 2020 11:30pm
127 Views
Post# 31684868

RE:RE:BANGARAG - OLI is FDA APPROVED!!!!!

RE:RE:BANGARAG - OLI is FDA APPROVED!!!!!TRVN must be HOT...The WEASEL is back WHACKIN'it!!

Best GG


<< Previous
Bullboard Posts
Next >>